VKTX
VKTX
US92686J1060
Viking Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
3.63B EUR
4.55B EUR
3.77B EUR
4.04B EUR
Enterprise Value
2.74B EUR
4.43B EUR
3.65B EUR
3.87B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-6.48x
--
--
--
Price to Sales
--
--
--
--
Price to Book
8.15x
11.14x
7.51x
6.32x
EV/Revenue
--
--
--
--
EV/EBITDA
--
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-6.37%
-9.2%
-9.02%
-5.61%
ende